Radiographic and magnetic resonance imaging of bone and soft-tissue tumors and myeloproliferative disorders.
New experience and new information in the field of musculoskeletal tumors and marrow disorders continue to be dominated by MR imaging. Much of the new information builds on what already has been established by MR imaging, namely its unrivaled position in staging musculoskeletal tumors and demonstrating the extent of marrow disease. MR imaging has now been evaluated for quantitative estimation of tumor necrosis following neoadjuvant therapy for sarcomas, characterization of soft-tissue masses, and its role in the treated patient with marrow disease. This review also includes some publications in the field of musculoskeletal tumors on radiography and nuclear MR spectroscopy.
Sundaram
M
M
St. Louis University Medical Center, Missouri.
D001853:Bone Marrow / Q000000981:diagnostic imaging / Q000473:pathology; D001859:Bone Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D002648:Child; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D011859:Radiography; D012983:Soft Tissue Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging*